Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 01, 2026
TickeronGET DAILY SIGNALS
VB vs VTWO: Weighing Vanguard Small-Cap ETF Choices

VB vs VTWO: Weighing Vanguard Small-Cap ETF Choices

Key Takeaways

  • Both VB and VTWO are passively managed, market-cap-weighted U.S. small-cap ETFs from Vanguard, but they track different indexes and serve subtly different exposure goals.
  • VB follows the CRSP US Small Cap Index with roughly 1,300 holdings and a slight mid-cap tilt, while VTWO follows the Russell 2000 Index with about 2,000 names and deeper micro-cap reach.
  • VB is marginally cheaper (0.05% versus 0.06% expense ratio) and far larger and more liquid, with assets under management (AUM) in excess of $160 billion versus roughly $18 billion for VTWO.
  • Sector tilts differ meaningfully: VB leans toward industrials and technology, while VTWO carries heavier healthcare and financials exposure.
  • VTWO offers broader diversification but higher volatility and a smaller average market capitalization, whereas VB's larger median cap profile has historically supported more consistent relative positioning.
  • Tickeron AI Verdict: VB (Vanguard Small-Cap ETF) is the favored ticker based on cost efficiency, liquidity, and sector momentum.

Why These Two ETFs Stand Out

Investors looking for broad U.S. small-cap exposure often come across two Vanguard funds that look similar at first glance: the Vanguard Small-Cap ETF (VB) and the Vanguard Russell 2000 ETF (VTWO). Both are index-tracking, market-cap-weighted products focused on the smaller end of the domestic equity market, yet they are not identical. The two ETFs compete for the same goal of diversified small-cap participation, but they differ in index construction, sector composition, size, and cost. In the current rate-sensitive environment, where small caps respond sharply to changes in borrowing costs and growth expectations, these structural differences matter for fund performance and positioning decisions.

A Closer Look at VB

VB is a passively managed fund that tracks the CRSP US Small Cap Index, covering the smaller segment of the U.S. equity universe. The fund holds roughly 1,324 stocks, though its weighted-average market capitalization of around $9.8 billion gives it a noticeable mid-cap tilt compared with purer small-cap offerings. This blend means VB tends to include somewhat larger, more established companies than a typical small-cap index.

Sector allocation leans toward industrials (approximately 19–20%), technology (about 18%), financial services (12–13%), and healthcare (roughly 11–14%). Top holdings remain highly diversified, with names such as EMCOR Group (EME), Ciena (CIEN), and Sandisk (SNDK) each well under 1% of assets, which helps limit single-stock risk. The expense ratio sits at 0.05%, among the lowest in the category, and the fund’s substantial AUM supports strong liquidity and tight spreads. When comparing options like this, I also checked this using Tickeron’s AI Screener to see how the fund stacks up against peers in the space.

A Closer Look at VTWO

VTWO is designed to track the Russell 2000 Index, the most widely referenced benchmark for U.S. small-cap stocks. With approximately 2,000 holdings and a weighted-average market capitalization near $3.9 billion, VTWO extends further down the size spectrum and captures more micro-cap and smaller small-cap names than VB.

The fund’s sector exposure is led by healthcare (roughly 18–20%), financials (about 17%), industrials (14–17%), and technology (13–15%). Top positions—including Bloom Energy (BE), Fabrinet (FN), Credo Technology (CRDO), and Twist Bioscience (TWST)—each account for well below 1% of the portfolio. The expense ratio is 0.06%, slightly higher than VB’s, and with roughly $18 billion in AUM, VTWO remains liquid but operates on a smaller scale than its counterpart.

Market Context for Small Caps

Small-cap equities tend to be particularly sensitive to interest-rate policy, credit conditions, and the path of economic growth. Because smaller companies often carry more floating-rate debt and thinner margins than large caps, their earnings and valuations can shift quickly with Federal Reserve moves. In the current setting, investors have rotated toward domestic, cyclical businesses that benefit from steady industrial activity, reshoring, and infrastructure spending, which has supported industrials and technology names.

At the same time, healthcare and financials—larger weights in VTWO—have encountered mixed influences from regulatory scrutiny, M&A activity, and bank balance-sheet factors. These sector differences, rather than any single event, help explain much of the relative performance gap between the two funds in recent cycles.

Performance and Positioning Insights

Over recent weeks and months, the two funds have moved in the same broad direction but diverged in magnitude, reflecting their distinct sector exposures and size profiles. VB’s overweight to industrials and technology has aligned it with areas of relative strength, while its larger median market capitalization has helped moderate downside volatility. VTWO’s heavier healthcare and financials tilt, combined with its deeper micro-cap exposure, has led to higher volatility, in line with its smaller average company size and greater sensitivity to credit conditions.

Neither fund uses leverage or follows a thematic approach; both simply provide market-beta exposure to the small-cap segment. Still, VB’s combination of quality-leaning sector exposure, lower cost, and stronger liquidity has supported steadier relative positioning, while VTWO delivers broader small-cap breadth at the expense of modestly higher risk and expense. One thing that stands out here is how these differences play out in rate-sensitive periods.

Using AI Tools in My Research

When evaluating funds like these, I find it helpful to run quick scans with Tickeron’s AI Screener to surface relative-strength signals and momentum patterns across the small-cap universe. It allows filtering by technical patterns, fundamentals, trends, and performance metrics, which makes comparing options like VB and VTWO more systematic than manual reviews alone. This approach has reinforced my view that VB holds a modest edge in the current setup.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VB, VTWO

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


VB sees MACD Histogram crosses below signal line

VB saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 53 instances where the indicator turned negative. In 46 of the 53 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VB as a result. In 75 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

VB moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VB crossed bearishly below the 50-day moving average on November 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for VB entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for VB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where VB advanced for three days, in 273 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

VB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Moderna (NASDAQ:MRNA), Centene Corp (NYSE:CNC), Illumina (NASDAQ:ILMN), Twilio (NYSE:TWLO), EQT Corp (NYSE:EQT), Okta (NASDAQ:OKTA), Incyte Corp (NASDAQ:INCY), Roku (NASDAQ:ROKU), Dow (NYSE:DOW), Southwest Airlines Co (NYSE:LUV).

Industry description

The investment seeks to track the performance of the CRSP U.S. Small Cap Index that measures the investment return of small-capitalization stocks. The fund advisor employs an indexing investment approach designed to track the performance of the CRSP U.S. Small Cap Index, a broadly diversified index of stocks of small U.S. companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard Morningstar Small-Cap ETF (VB) ETF is 6.65B. The market cap for tickers in the group ranges from 203.84M to 101.48B. MRNA holds the highest valuation in this group at 101.48B. The lowest valued company is CCOI at 203.84M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was -7%. For the same ETF, the average monthly price growth was -6%, and the average quarterly price growth was -6%. BRBR experienced the highest price growth at 38%, while YSS experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Vanguard Morningstar Small-Cap ETF (VB) ETF was 45%. For the same stocks of the ETF, the average monthly volume growth was 38% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 53
Price Growth Rating: 53
SMR Rating: 64
Profit Risk Rating: 76
Seasonality Score: 13 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.